InsidersTradesSigma
Sino Biopharmaceutical Ltd.: directors' dealings · Hong Kong · HKEX
HKEX:sino-biopharmaceutical-ltdHK·HKEXMcap 94.6Bn€Healthcare
Explore the full directors' dealings record of Sino Biopharmaceutical Ltd., a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the oversight of HKEX. Operating in the Healthcare sector, Sino Biopharmaceutical Ltd. has logged 6 public disclosures. Market capitalisation: €94.6bn. The latest transaction was reported on 30 April 2026 — Purchase. Among the most active insiders: Cheng Cheung Ling. The full history is free.
6
Insider Decl.
0
Thresholds
€8m
6 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
5.30 €
Analyst consensus
19 analystsStrong buy
7.11 €Target 8.87 €(+67%)10.54 €
Income statement
Revenue31.83 Bn€
Gross profit26.13 Bn€82% margin
Net income2.34 Bn€7.4% margin
Valuation
PER (trailing)35.3x
PER (forward)19.8x
P/Book2.7x
Beta0.64
Balance sheet & cash
Market cap94.60 Bn€
Total debt16.07 Bn€
Free Cash Flow7.59 Bn€
Debt / Equity38%
Profitability & ownership
ROE12.5%
ROA5.6%
% insiders48.5%
% institutions20.6%
Last declaration on 30 April 2026
Declarations0 total
No declarations found
0 of 0 declarations